CVS Health Corporation (CVS)

CVS Health Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	134,023	100,867	56,561	101,700	121,147	136,378
Market Cap Growth	74.54%	78.33%	-44.38%	-16.05%	-11.17%	52.42%
Enterprise Value	200,031	170,387	128,658	169,805	175,767	200,158
Last Close Price	105.04	79.36	44.89	78.96	93.19	103.16

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	46.14	57.09	12.27	12.20	28.59	17.14
Forward PE	13.85	11.54	7.77	9.39	10.67	12.88
PEG Ratio	1.16	0.76	0.61	1.92	2.05	2.15
PS Ratio	0.33	0.25	0.15	0.28	0.38	0.47
PB Ratio	1.74	1.34	0.75	1.33	1.70	1.82
P/FCF Ratio	18.05	12.92	8.94	9.78	9.01	8.66
P/OCF Ratio	12.92	9.48	6.21	7.57	7.49	7.47

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	0.49	0.42	0.35	0.47	0.55	0.69
EV/EBITDA Ratio	33.53	18.39	9.81	9.38	14.43	11.25
EV/EBIT Ratio	33.53	36.56	15.11	12.36	22.10	15.04
EV/FCF Ratio	27.05	21.82	20.34	16.34	13.07	12.71

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	0.95	0.98	1.02	0.98	0.96	0.93
Debt / EBITDA Ratio	13.13	8.63	6.32	4.38	5.75	4.27
Debt / FCF Ratio	10.60	10.24	13.11	7.64	5.21	4.83
Net Debt / Equity Ratio	0.86	0.92	0.95	0.89	0.76	0.85
Net Debt / EBITDA Ratio	11.15	7.49	5.49	3.75	4.46	3.57
Net Debt / FCF Ratio	9.00	8.88	11.37	6.54	4.04	4.03
Asset Turnover	1.61	1.59	1.48	1.50	1.40	1.26
Inventory Turnover	18.98	18.56	17.79	16.35	14.54	13.24
Quick Ratio	0.61	0.57	0.56	0.59	0.62	0.55
Current Ratio	0.87	0.84	0.81	0.86	0.95	0.88
Return on Equity (ROE)	3.79%	2.29%	6.02%	11.28%	5.88%	11.01%
Return on Assets (ROA)	1.98%	1.49%	2.53%	4.31%	2.56%	4.35%
Return on Invested Capital (ROIC)	3.47%	2.58%	4.35%	7.61%	4.45%	7.14%
Return on Capital Employed (ROCE)	3.60%	2.79%	5.02%	8.34%	4.91%	7.97%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	2.20%	1.75%	8.15%	8.19%	3.50%	5.84%
FCF Yield	5.54%	7.74%	11.18%	10.22%	11.10%	11.55%
Dividend Yield	2.54%	3.38%	5.97%	3.09%	2.38%	1.93%
Payout Ratio	115.88%	192.14%	73.10%	37.54%	67.43%	32.81%
Buyback Yield / Dilution	-1.07%	-0.71%	2.17%	2.49%	0.45%	-1.14%
Total Shareholder Return	1.47%	2.67%	8.14%	5.58%	2.83%	0.79%

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: May 6, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 29, 2026

Data Sources Report a data error